Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 3 studies | 32% ± 19% |
Insufficient scRNA-seq data for expression of MYOC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 75% | 3136.14 | 487 / 653 | 26% | 2.24 | 155 / 605 |
esophagus | 73% | 9161.55 | 1052 / 1445 | 22% | 2.78 | 41 / 183 |
blood vessel | 92% | 5863.97 | 1228 / 1335 | 0% | 0 | 0 / 0 |
prostate | 18% | 492.92 | 44 / 245 | 72% | 4.57 | 363 / 502 |
stomach | 63% | 4619.02 | 227 / 359 | 16% | 1.78 | 46 / 286 |
adipose | 78% | 4009.23 | 938 / 1204 | 0% | 0 | 0 / 0 |
bladder | 71% | 2336.95 | 15 / 21 | 6% | 0.62 | 31 / 504 |
muscle | 63% | 1768.34 | 509 / 803 | 0% | 0 | 0 / 0 |
breast | 46% | 1832.14 | 213 / 459 | 7% | 3.89 | 83 / 1118 |
intestine | 41% | 850.05 | 395 / 966 | 12% | 1.57 | 63 / 527 |
kidney | 0% | 0 | 0 / 89 | 42% | 1.87 | 382 / 901 |
heart | 36% | 658.73 | 314 / 861 | 0% | 0 | 0 / 0 |
lung | 26% | 514.88 | 152 / 578 | 9% | 0.87 | 101 / 1155 |
uterus | 23% | 781.32 | 39 / 170 | 11% | 16.13 | 52 / 459 |
skin | 10% | 137.39 | 188 / 1809 | 16% | 12.48 | 76 / 472 |
ovary | 3% | 49.49 | 6 / 180 | 12% | 1.76 | 50 / 430 |
pancreas | 1% | 12.70 | 4 / 328 | 9% | 0.37 | 16 / 178 |
eye | 0% | 0 | 0 / 0 | 10% | 1.19 | 8 / 80 |
adrenal gland | 0% | 3.76 | 1 / 258 | 8% | 2.20 | 19 / 230 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.16 | 2 / 45 |
brain | 0% | 0.90 | 1 / 2642 | 1% | 0.26 | 8 / 705 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
GO_0038133 | Biological process | ERBB2-ERBB3 signaling pathway |
GO_0051901 | Biological process | positive regulation of mitochondrial depolarization |
GO_0051496 | Biological process | positive regulation of stress fiber assembly |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0031175 | Biological process | neuron projection development |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0007165 | Biological process | signal transduction |
GO_0045162 | Biological process | clustering of voltage-gated sodium channels |
GO_0001953 | Biological process | negative regulation of cell-matrix adhesion |
GO_0022011 | Biological process | myelination in peripheral nervous system |
GO_0014734 | Biological process | skeletal muscle hypertrophy |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0051894 | Biological process | positive regulation of focal adhesion assembly |
GO_1900026 | Biological process | positive regulation of substrate adhesion-dependent cell spreading |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0043408 | Biological process | regulation of MAPK cascade |
GO_0060348 | Biological process | bone development |
GO_0051497 | Biological process | negative regulation of stress fiber assembly |
GO_0005615 | Cellular component | extracellular space |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005929 | Cellular component | cilium |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0033268 | Cellular component | node of Ranvier |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005791 | Cellular component | rough endoplasmic reticulum |
GO_0005109 | Molecular function | frizzled binding |
GO_0001968 | Molecular function | fibronectin binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0032027 | Molecular function | myosin light chain binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | MYOC |
Protein name | Myocilin trabecular meshwork inducible glucocorticoid response isoform 5 Myocilin trabecular meshwork inducible glucocorticoid response isoform 4 Myocilin (Trabecular meshwork-induced glucocorticoid response protein) Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)] Myocilin trabecular meshwork inducible glucocorticoid response isoform 3 Myocilin |
Synonyms | TIGR GLC1A |
Description | FUNCTION: Secreted glycoprotein regulating the activation of different signaling pathways in adjacent cells to control different processes including cell adhesion, cell-matrix adhesion, cytoskeleton organization and cell migration. Promotes substrate adhesion, spreading and formation of focal contacts. Negatively regulates cell-matrix adhesion and stress fiber assembly through Rho protein signal transduction. Modulates the organization of actin cytoskeleton by stimulating the formation of stress fibers through interactions with components of Wnt signaling pathways. Promotes cell migration through activation of PTK2 and the downstream phosphatidylinositol 3-kinase signaling. Plays a role in bone formation and promotes osteoblast differentiation in a dose-dependent manner through mitogen-activated protein kinase signaling. Mediates myelination in the peripheral nervous system through ERBB2/ERBB3 signaling. Plays a role as a regulator of muscle hypertrophy through the components of dystrophin-associated protein complex. Involved in positive regulation of mitochondrial depolarization. Plays a role in neurite outgrowth. May participate in the obstruction of fluid outflow in the trabecular meshwork. . |
Accessions | ENST00000037502.11 A0A1W2PP09 A0A140CTX2 Q99972 B6V6K6 A0A7T6ZKF8 A0A0S2Z481 ENST00000638471.1 A0A0H3W5P3 B6ECI7 A0A7T6ZK44 A0A7G3V676 A0A140CTX3 B6V6K7 A0A7T6ZL00 A0A7T6ZK79 A0A0S2Z421 A0A140CTX4 A0A140CTW9 A0A7T6ZK47 A0A140CTX1 A0A0S2Z412 Q6PKX1 A0A140CTX0 A0A0S2Z416 |